Company / Financials
STAAR Surgical Company Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$239.4M
FY2025 · -23.7% YoY
Net Income
-$80.4M
FY2025 · -298.1% YoY
Profit Margin
-33.6%
FY2025 · net income / revenue
ROE
-23.4%
FY2025 · return on equity
Total Assets
$451.7M
FY2025
Total Debt
-
FY2025
Equity
$344.2M
FY2025
ROA
-17.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$239.4M-23.7% YoYNet Income HistoryProfit after all expenses and taxes-$80.4M-298.1% YoYGross Profit HistoryRevenue minus cost of goods sold$182.4M-23.9% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$57.0M-23.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$91.7M-627.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$274.1M+8.7% YoYR&D Expense HistoryResearch and development spending$40.1M-11.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$78.0KIncome Tax HistoryTotal income tax expense-$1.8M-116.3% YoYEPS (Basic) HistoryBasic earnings per share$0.44-47.0% YoY